Literature DB >> 24761414

Long-term outcome of crossover femoro-femoro-popliteal bypass using side-to-side anastomosis in ilio-femoral occlusive disease.

Yoon-Sub Kim1, Woo-Sung Yun1, Kihyuk Park1.   

Abstract

PURPOSE: During crossover femoro-femoro-popliteal sequential bypass (CFFPB) surgery in ilio-femoral occlusive disease, proximal anastomosis of the femoro-popliteal bypass is usually performed distal to the distal anastomosis of the crossover femoro-femoral bypass. If not, it is done with a piggyback configuration. Another method is a side-to-side anastomosis. Its benefit is that this is the only anastomosis made. And it is less bulky compared with the piggyback configuration. This study was aimed to investigate the long-term outcome of CFFPB using side-to-side anastomosis.
METHODS: From Sep 2006 to Aug 2012, 21 patients who underwent CFFPB using side-to-side anastomosis were enrolled. Externally supported polytetrafluoroethylene graft was used as a conduit in all patients. Patient demographic data and procedure details were investigated. Primary graft patency was calculated using the Kaplan-Meier method.
RESULTS: The mean age of patients was 79 years (range, 62-81 years) and males were 17 (81%). Fifteen patients (71%) had critical limb ischemia. Inflow arteries comprised of 16 common femoral artery (CFA), 4 superficial femoral artery (SFA), and 1 deep femoral artery (DFA). Side-to-side anastomosis was performed on the CFA in 11, SFA in 2, and DFA in 8 patients. During the mean follow-up period of 21 months (1-60 months), 8 patients died. The 1-, 3-, and 5-year primary patency rates were 76%, 63%, and 63%.
CONCLUSION: Long-term patency of CFFPB using side-to-side anastomosis was acceptable. It can be one of the treatment options for patients with ilio-femoral occlusive disease.

Entities:  

Keywords:  Anastomosis; Bypass surgery

Year:  2014        PMID: 24761414      PMCID: PMC3994596          DOI: 10.4174/astr.2014.86.2.91

Source DB:  PubMed          Journal:  Ann Surg Treat Res        ISSN: 2288-6575            Impact factor:   1.859


  10 in total

1.  Prosthetic above-knee femoropopliteal bypass grafting: five-year results of a randomized trial.

Authors:  R M Green; W M Abbott; T Matsumoto; J R Wheeler; N Miller; F J Veith; S Money; H E Garrett
Journal:  J Vasc Surg       Date:  2000-03       Impact factor: 4.268

2.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

3.  Critical appraisal of femorofemoral crossover grafts.

Authors:  R Pursell; E Sideso; T R Magee; R B Galland
Journal:  Br J Surg       Date:  2005-05       Impact factor: 6.939

4.  A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study.

Authors:  W C Johnson; K K Lee
Journal:  J Vasc Surg       Date:  2000-08       Impact factor: 4.268

5.  Prospective controlled study of polytetrafluoroethylene versus saphenous vein in claudicant patients with bilateral above knee femoropopliteal bypasses.

Authors:  A F AbuRahma; P A Robinson; S M Holt
Journal:  Surgery       Date:  1999-10       Impact factor: 3.982

6.  Factors affecting the long-term patency of crossover femorofemoral bypass graft.

Authors:  Y W Kim; J-H Lee; H G Kim; S Huh
Journal:  Eur J Vasc Endovasc Surg       Date:  2005-10       Impact factor: 7.069

7.  Femorofemoral bypass grafts: Factors influencing long-term patency rate and outcome.

Authors:  A Mingoli; P Sapienza; R J Feldhaus; L Di Marzo; C Burchi; A Cavallaro
Journal:  Surgery       Date:  2001-04       Impact factor: 3.982

8.  Femorofemoral versus aortobifemoral bypass: outcome and hemodynamic results.

Authors:  J R Schneider; S R Besso; D B Walsh; R M Zwolak; J L Cronenwett
Journal:  J Vasc Surg       Date:  1994-01       Impact factor: 4.268

9.  Iliofemoral versus femorofemoral bypass: the case for an individualized approach.

Authors:  M E Harrington; E B Harrington; M Haimov; H Schanzer; J H Jacobson
Journal:  J Vasc Surg       Date:  1992-12       Impact factor: 4.268

Review 10.  Femorofemoral bypass graft: analysis of patency and factors influencing long-term outcome.

Authors:  E Criado; S J Burnham; E A Tinsley; G Johnson; B A Keagy
Journal:  J Vasc Surg       Date:  1993-09       Impact factor: 4.268

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.